Broadridge Financial Solutions
BR
$143.88
+0.77%
Broadridge Financial Solutions Inc. is a leading provider of investor communication and technology-driven solutions, operating within the financial technology and information technology services industry. The company serves banks, broker-dealers, asset managers, and corporate issuers through two primary segments: investor communication solutions and global technology and operations. As a dominant market player, Broadridge is a critical infrastructure provider for the capital markets, known for its high recurring revenue base and essential services in proxy voting, regulatory reporting, and wealth management platforms. The current investor narrative is dominated by a significant stock price decline, raising questions about the company's growth trajectory and margin resilience, with recent quarterly results showing mixed performance and likely driving debate over its ability to navigate a challenging macro environment for financial services technology.…
BR
Broadridge Financial Solutions
$143.88
Investment Opinion: Should I buy BR Today?
Rating & Thesis: Hold. Broadridge is a financially stable company with a critical market position, but it is currently caught in a transition phase where decelerating growth and margin pressure offset its attractive forward valuation and cash flow, warranting a neutral stance pending clearer signs of operational stabilization.
Supporting Evidence: The forward P/E of 13.9x is compelling and represents a 59% discount to the trailing multiple, implying significant earnings recovery is priced in. However, this optimism is challenged by decelerating revenue growth (7.85% YoY vs. prior double-digit rates) and contracting gross margins (27.63% vs. 31.02% a year ago). The company's robust TTM free cash flow of $1.36B and essential service model provide a floor, but the elevated PEG ratio of 1.62 suggests the stock is not unequivocally cheap on a growth-adjusted basis. The technical picture, with the stock down 39.6% YTD and near its 52-week low, reflects these fundamental concerns.
Risks & Conditions: The two biggest risks are a further decline in revenue growth below 5% and a failure to stabilize gross margins above 28%. This Hold rating would upgrade to a Buy if the company demonstrates a clear re-acceleration of organic growth to above 10% and gross margins recover to above 30% in the next two quarters. It would downgrade to a Sell if revenue growth turns negative or if the forward P/E expands back above 20x without corresponding earnings improvements. Relative to its own historical valuation range (trailing P/E between ~16x and 86x) and given the growth deceleration, the stock appears fairly valued to slightly overvalued at current levels, as the market is still pricing in a significant earnings recovery that is not yet evident in the operational data.
Sign up to view all
BR 12-Month Price Forecast
The investment case for Broadridge is balanced on a knife's edge between value and value trap. The severe price decline has created an attractive forward valuation, but this is entirely dependent on the company arresting the decline in its growth and profitability metrics. The base case of sideways consolidation is most likely, as the market waits for confirmation that operational headwinds are temporary. The stance would upgrade to Bullish on evidence of gross margin stabilization above 28% and revenue growth holding above 8%. It would downgrade to Bearish if the stock breaks below $139.79 with high volume, signaling a new leg down in the downtrend.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Broadridge Financial Solutions's 12-month outlook, with a consensus price target around $187.04 and implied upside of +30.0% versus the current price.
Average Target
$187.04
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$115 - $187
Analyst target range
Analyst coverage for Broadridge is limited, with only 3 analysts providing estimates, indicating this is a mid-cap stock with less institutional scrutiny, which can lead to higher volatility and less efficient price discovery. The consensus among the limited coverage appears mixed, with recent institutional ratings showing a mix of 'Buy' and 'Neutral'/'Equal Weight' stances, such as DA Davidson upgrading to Buy in February 2026 while JP Morgan maintains a Neutral rating. The average revenue estimate for the period is $8.84 billion, with a tight range between $8.78B and $8.93B, and the average EPS estimate is $13.80, ranging from $13.68 to $13.98, but a specific consensus price target and implied upside are not available in the provided data, preventing a calculation of the market's implied price expectation.
Bulls vs Bears: BR Investment Factors
The evidence currently favors the bear case, primarily due to the sharp deceleration in revenue growth and significant margin compression, which directly challenge the core investment thesis of a stable, high-quality business. The bull case rests on the attractive forward P/E and strong free cash flow, suggesting the market may have over-punished the stock. The single most important tension in the investment debate is whether the current 7.85% revenue growth and 27.63% gross margin represent a new, lower normal for the business, or if they are a temporary trough from which the company can recover to its historical mid-teen growth and 30%+ gross margins. The resolution of this margin and growth trajectory will determine if the stock is a deep-value opportunity or a value trap.
Bullish
- Strong Free Cash Flow & Liquidity: Broadridge generates substantial free cash flow, with TTM FCF of $1.36B. This provides a robust buffer for operations, dividends, and share repurchases, supporting financial stability despite recent price weakness.
- Attractive Forward Valuation: The stock trades at a forward P/E of 13.9x, a significant discount to its trailing P/E of 33.9x. This suggests the market has already priced in a significant earnings slowdown, potentially creating a value opportunity if forward EPS of $13.80 is achieved.
- Essential, Recurring Revenue Model: As a critical infrastructure provider for capital markets, Broadridge's business model is built on high recurring revenue from investor communications and regulatory services. This provides a degree of revenue stability even in volatile markets.
- Technical Oversold Condition: The stock is down 39.6% over the past year and trades just 4% above its 52-week low of $139.79. This deep oversold condition, coupled with a beta of 0.89, suggests the severe sell-off may have overreacted to company-specific concerns.
Bearish
- Severe Growth Deceleration: Revenue growth has decelerated sharply to 7.85% YoY in the latest quarter, down from 13.6% in Q1 FY2026. This trend raises significant concerns about the company's ability to sustain its historical growth trajectory and justify its valuation.
- Significant Margin Compression: Gross margin contracted to 27.63% in Q2 FY2026 from 31.02% a year prior. This 339 basis point decline indicates rising cost pressures or unfavorable business mix, directly threatening profitability and the forward earnings estimates.
- Elevated Trailing Valuation Metrics: Despite the price collapse, the stock's trailing P/E of 33.9x and Price/Sales of 4.13x remain elevated. The PEG ratio of 1.62 suggests the stock is not cheap on a growth-adjusted basis, questioning the sustainability of a rebound.
- Persistent Technical Downtrend: The stock is in a clear downtrend, underperforming the SPY by -62.5% over the past year. With a max drawdown of -46.3% and no clear reversal pattern, it remains a 'falling knife,' indicating continued negative momentum and investor sentiment.
BR Technical Analysis
The stock is in a pronounced and sustained downtrend, with a 1-year price change of -39.59%, placing it near the bottom of its 52-week range. With a current price of $144.87 against a 52-week high of $271.91 and low of $139.79, the stock is trading at only 4% above its 52-week low, indicating it is in deep oversold territory and may represent a potential value opportunity, though it remains a 'falling knife' until a clear reversal pattern emerges. The short-term momentum is also negative but shows signs of attempted stabilization; the 1-month price change is a modest +0.65%, while the 3-month change is -18.76%, suggesting the severe selling pressure may be abating, though the stock has significantly underperformed the SPY, which is up 22.86% over the past year, as evidenced by a relative strength of -62.45%. Key technical support is firmly established at the 52-week low of $139.79, while resistance is far above at the 52-week high of $271.91; a decisive break below support could trigger another leg down, while a sustained move above the recent consolidation range is needed to signal a potential trend reversal. With a beta of 0.888, the stock has exhibited slightly less volatility than the broader market during this downturn, which is noteworthy given its substantial price decline, indicating the sell-off has been driven more by company-specific factors than broad market risk.
Beta
0.89
0.89x market volatility
Max Drawdown
-46.5%
Largest decline past year
52-Week Range
$140-$272
Price range past year
Annual Return
-39.8%
Cumulative gain past year
| Period | BR Return | S&P 500 |
|---|---|---|
| 1m | -1.2% | +1.5% |
| 3m | -17.8% | +13.4% |
| 6m | -36.5% | +10.9% |
| 1y | -39.8% | +24.5% |
| ytd | -34.7% | +10.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BR Fundamental Analysis
Broadridge's revenue trajectory shows modest but decelerating growth, with the most recent quarterly revenue of $1.71 billion representing a 7.85% year-over-year increase; however, this growth rate is down from the double-digit increases seen in prior quarters, such as the 13.6% YoY growth in Q1 FY2026, indicating potential headwinds. The company remains profitable with a net income of $284.6 million in its latest quarter, but profitability metrics are volatile; the gross margin for the quarter was 27.63%, which is down from 31.02% a year prior, and the net margin of 16.6% is healthy but has fluctuated significantly from a low of 5.6% in Q1 FY2025 to a high of 18.1% in Q4 FY2025, reflecting earnings volatility. The balance sheet shows moderate leverage with a debt-to-equity ratio of 1.30, and the company generates substantial free cash flow, with TTM free cash flow of $1.36 billion, providing ample liquidity to fund operations, dividends, and share repurchases; however, the current ratio of 0.98 indicates potential short-term liquidity constraints, though the robust cash generation from operations mitigates this concern.
Quarterly Revenue
$1.7B
2025-12
Revenue YoY Growth
+0.07%
YoY Comparison
Gross Margin
+0.27%
Latest Quarter
Free Cash Flow
$1.4B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BR Overvalued?
Given a positive net income of $284.6 million, the primary valuation metric is the P/E ratio. The trailing P/E is elevated at 33.9x, while the forward P/E is significantly lower at 13.9x, indicating the market expects a substantial recovery in earnings, with the forward estimate implying a 59% discount to the trailing multiple, which suggests either depressed current earnings are expected to normalize or future growth is priced in aggressively. Compared to sector averages, Broadridge trades at a premium on a Price/Sales basis with a PS ratio of 4.13, though industry comparables are not provided; the elevated trailing P/E and moderate PEG ratio of 1.62 suggest the stock is not cheap on an absolute basis, but the forward multiple implies a more reasonable valuation if earnings estimates are met. Historically, the stock's own trailing P/E of 33.9x is above its recent range observed in the historical ratios data, where it has fluctuated between approximately 16x and 86x over the past several quarters, placing it in the upper-middle band of its own historical valuation, which suggests the market is still pricing in a relatively optimistic earnings recovery despite the severe price decline.
PE
33.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 15x~113x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
18.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Broadridge faces significant financial risks from its volatile profitability and margin pressure. The quarterly net margin has fluctuated wildly from a low of 5.6% to a high of 18.1% over the past two years, and the recent gross margin contraction of over 300 basis points year-over-year is a major red flag. While the company has a moderate debt-to-equity ratio of 1.30, its current ratio of 0.98 indicates potential short-term liquidity constraints, though this is mitigated by its strong TTM free cash flow of $1.36B. The primary risk is that the decelerating revenue growth (down to 7.85% YoY) becomes a sustained trend, failing to support the forward earnings estimates of $13.80 per share.
Market & Competitive Risks: The stock's valuation presents a key market risk. Despite the 40% price decline, its trailing P/E of 33.9x and PS ratio of 4.13 suggest it still trades at a premium, leaving it vulnerable to further multiple compression if growth disappoints. As a financial technology provider, the company is sensitive to cyclical downturns in capital markets activity and spending by its bank and asset manager clients. The stock's beta of 0.888 indicates it is not immune to broader market sell-offs. Furthermore, with only 3 analysts covering the stock, it suffers from lower institutional scrutiny, which can exacerbate volatility and mispricing during periods of uncertainty.
Worst-Case Scenario: The worst-case scenario involves a continuation of the current negative trends: revenue growth decelerates further below 5%, gross margins fail to recover from the 27.6% level, and the company misses forward EPS estimates. This would trigger multiple analyst downgrades from the current mixed 'Buy/Neutral' stance, leading to a re-rating towards a lower forward P/E multiple (e.g., 10-12x). Combined with a reduction in earnings estimates, this could drive the stock price to re-test and break below its 52-week low of $139.79. A realistic downside from the current price of $144.87 would be a further 15-20% decline, targeting a range of $116-$123, which aligns with a forward P/E of ~10x on potentially lowered earnings.
FAQ
The key risks are, in order of severity: 1) Operational Deterioration: Further deceleration in revenue growth below 5% and continuation of gross margin contraction below 27%, which would crush forward earnings estimates. 2) Vational Compression: The stock's elevated trailing multiples (P/E 33.9x, PS 4.13x) leave it vulnerable to de-rating if growth stalls. 3) Market Sensitivity: As a provider to financial institutions (beta 0.89), its business is cyclical and could suffer in an economic downturn. 4) Liquidity & Leverage: A current ratio below 1 (0.98) indicates tight working capital, though substantial FCF mitigates this. The debt-to-equity of 1.30 adds financial risk if interest rates remain elevated.
The 12-month forecast for BR is wide-ranging, reflecting high uncertainty. The base case (55% probability) sees the stock trading between $150 and $170 as growth stabilizes in the mid-single digits. The bull case (25% probability) targets $180-$200, contingent on a re-acceleration of growth and margin recovery. The bear case (20% probability) warns of a drop to $120-$140 if operational metrics worsen. The most likely scenario is the base case, predicated on the assumption that the company's revenue growth stabilizes around 7-8% and margins stop declining. The key variable is the next quarter's gross margin figure.
BR sends mixed valuation signals. On a trailing basis, it appears overvalued with a P/E of 33.9x and a PEG ratio of 1.62 given its slowing growth. However, the forward P/E of 13.9x suggests the market expects a sharp earnings recovery and prices the stock at a significant discount to its recent history. Compared to sector averages, its Price/Sales ratio of 4.13 is elevated, indicating a premium for its business model. Overall, the stock is likely fairly valued to slightly overvalued relative to its near-term growth prospects, but could be undervalued if the company returns to its historical growth and margin profile.
BR presents a high-risk, high-potential-reward opportunity at current levels. For value investors with a 2-3 year horizon, the forward P/E of 13.9x and strong free cash flow yield may be attractive, suggesting the 40% price decline has overcorrected. However, for most investors, it is not a clear 'good buy' today due to the unresolved fundamental headwinds of decelerating revenue growth (7.85% YoY) and significant gross margin compression. It could be a good buy for contrarians who believe the operational issues are temporary, but it requires a high risk tolerance and conviction that management can execute a turnaround.
BR is unsuitable for short-term trading due to its high volatility, lack of near-term positive catalysts, and entrenched downtrend. It is best suited for long-term investors with a minimum 3-year horizon who can look through the current cyclical weakness. The company's essential market position and strong cash flow generation support a long-term holding thesis, but investors must be prepared for further volatility as the company works to stabilize its business. The low dividend yield of 1.4% does not provide significant income support, making this primarily a capital appreciation story dependent on a successful operational turnaround.
